To roughly assess what we are up against in the treatment of symptomatic AD, when the AβPP-independent iAβ production pathway is operational, it is instructive to compare the efficiencies of generation of iAβ in the AβPP proteolytic and AβPP-independent pathways. Here, APP is linked to Alzheimer disease.